FitzPatrick Margaret M 4
4 · VistaGen Therapeutics, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
FitzPatrick Margaret M
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+100,000→ 100,000 totalExercise: $1.37Exp: 2032-03-01→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, which vest in twelve equal monthly installments, beginning on the date of the grant.